highdos
corticosteroid
therapi
inflammatori
diseas
autoimmun
diseas
report
risk
factor
nontraumat
osteonecrosi
femor
head
onfh
hand
report
megados
corticosteroid
therapi
traumat
spinal
cord
injuri
induc
nontraumat
thu
role
corticosteroid
pathogenesi
nontraumat
onfh
poorli
understood
previous
report
tolllik
receptor
tlr
signal
pathway
induc
inflammatori
statu
contribut
pathogenesi
nontraumat
onfh
tlr
identifi
receptor
relat
innat
immun
system
recent
tlr
report
play
crucial
role
particular
tlr
contribut
pathogenesi
underli
diseas
system
lupu
erythematod
sle
nephrot
syndrom
polymyositisdermatmyos
bronchial
asthma
thrombocytopen
purpura
patient
corticosteroidinduc
signal
pathway
via
type
interferon
may
particular
contribut
pathogenesi
system
autoimmun
diseas
inhibitor
biolog
develop
downregul
signal
pathway
treatment
inflammatori
reason
use
corticosteroid
therapi
inflammatori
diseas
relat
antiinflammatori
immunosuppress
activ
report
reduct
nuclear
factor
kappa
b
activ
via
glucocorticoid
receptor
central
role
interferon
regulatori
factor
signal
transcript
factor
relat
proinflammatori
respons
via
pathway
thu
hypothes
administr
ligand
subsequ
treatment
methylprednisolon
mpsl
lead
onfh
rat
transcript
factor
may
contribut
pathogenesi
onfh
via
tlr
present
studi
verifi
hypothesi
investig
incid
onfh
rat
administr
ligand
combin
mpsl
whether
contribut
pathogenesi
onfh
mpsl
treatment
experi
conduct
accord
guidelin
ministri
sport
cultur
scienc
technolog
japan
follow
protocol
approv
anim
ethic
committe
sapporo
medic
univers
male
wistar
rat
g
obtain
sankyo
labo
servic
sapporo
japan
anim
hous
temperatur
humiditycontrol
room
unlimit
food
water
lightdark
cycl
anim
divid
five
group
treat
follow
tabl
salinempsl
rat
given
salin
mlkg
subcutan
day
mgkg
mpsl
sigma
st
loui
mo
usa
intramuscularli
day
imiquimodsalin
rat
given
mgkg
imiquimod
tokyo
chemic
industri
tokyo
japan
ligand
subcutan
day
salin
mlkg
intramuscularli
day
imiquimodmpsl
rat
given
mgkg
imiquimod
subcutan
day
mgkg
mpsl
intramuscularli
day
cpgcmpsl
rat
given
mgkg
cpgc
ligand
subcutan
day
mgkg
mpsl
intramuscularli
day
rat
given
mgkg
imiquimod
subcutan
day
mgkg
sigma
inhibitor
kappab
kinas
ikk
potenti
inhibit
intraperitoneali
mgkg
mpsl
intramuscularli
day
inject
perform
pm
anim
kill
day
last
inject
femur
liver
harvest
fix
phosphat
buffer
ph
bone
sampl
decalcifi
kalkitox
wako
pure
chemic
industri
osaka
japan
neutral
sodium
sulfat
buffer
tissu
process
routin
hematoxylin
eosin
stain
assess
gener
architectur
onfh
osteonecrosi
defin
present
studi
diffus
presenc
empti
lacuna
pyknot
nuclei
osteocyt
within
bone
trabecula
accompani
surround
bone
marrow
cell
activ
assess
electrophoret
mobil
shift
assay
describ
brief
equal
amount
liver
nuclear
extract
mg
protein
incub
h
room
temperatur
consensu
oligonucleotid
probe
respect
bind
buffer
mm
hepe
ph
mm
kcl
mm
ethylenediaminetetraacet
acid
mm
dithiothreitol
glycerol
dna
protein
complex
separ
nondenatur
polyacrylamid
gel
constant
voltag
v
room
temperatur
gel
expos
imag
plate
fuji
film
tokyo
japan
room
temperatur
radioact
dnabind
complex
gel
analyz
use
imag
analyz
fuji
film
imagequ
softwar
molecular
dynam
sunnyval
ca
usa
data
repres
comparison
two
group
perform
use
fisher
exact
test
unpair
ttest
welch
correct
pvalu
consid
signific
statist
analysi
perform
use
graphpad
prism
softwar
mac
os
x
graphpad
softwar
la
jolla
ca
usa
evalu
incid
onfh
rat
salinempsl
use
control
imiquimodmpsl
cpgcmpsl
group
kill
day
mpsl
inject
onfh
observ
rat
imiquimodmpsl
group
rat
cpgcmpsl
group
contrast
onfh
observ
salinempsl
group
tabl
incid
onfh
imiquimodmpsl
group
significantli
higher
salinempsl
group
p
fisher
exact
test
figur
show
histopatholog
appear
femor
head
hematoxylin
eosin
stain
salinempsl
imiquimodmpsl
b
cpgcmpsl
c
rat
normal
trabecula
well
hematopoiet
fat
cell
observ
salinempsl
rat
figur
imiquimodmpsl
cpgcmpsl
group
empti
lacuna
pyknot
nuclei
observ
within
necrot
bone
trabecula
bone
marrow
cell
necrosi
observ
medullari
space
across
area
femor
head
figur
c
elucid
precis
time
onset
onfh
rat
evalu
effect
mpsl
onfh
develop
imiquimodsalin
use
control
group
imiquimodmpsl
group
group
significantli
develop
onfh
compar
salinempsl
group
divid
four
equal
subgroup
one
subgroup
treatment
group
killd
day
respect
last
treatment
detect
chang
led
develop
onfh
tabl
show
incid
onfh
group
onfh
observ
imiquimodsalin
imiquimodmpsl
rat
kill
day
respect
figur
show
histopatholog
appear
femor
head
hematoxylin
eosin
stain
imiquimodsalin
rat
onfh
without
onfh
b
day
empti
lacuna
observ
within
necrot
bone
trabecula
bone
marrow
cell
show
fat
cell
necrosi
observ
medullari
space
across
area
femor
head
observ
imiquimodmpsl
cpgcmpsl
rat
figur
normal
trabecula
well
hematopoiet
fat
cell
observ
femor
head
observ
salinempsl
rat
figur
present
studi
found
onfh
occur
within
day
mpsl
treatment
rat
figur
show
activ
transcript
factor
liver
activ
repress
significantli
rat
treat
mpsl
day
administr
tlr
ligand
figur
imiquimodsalin
vs
imiquimodmpsl
vs
p
howev
mpsl
treatment
alter
activ
phase
either
group
figur
describ
observ
chang
transcript
factor
activ
liver
h
mpsl
treatment
hypothes
chang
might
trigger
onset
primari
corticosteroidinduc
onfh
repress
activ
use
inhibitor
could
interfer
develop
onfh
spite
simultan
repress
activ
result
mpsl
treatment
clarifi
hypothesi
receiv
mgkg
respect
group
kill
day
mpsl
treatment
tabl
show
incid
onfh
group
coadministr
mpsl
found
interfer
develop
onfh
dosedepend
manner
group
coadminist
mgkg
onfh
observ
mpsl
treatment
incid
onfh
group
coadminist
mgkg
significantli
less
imiquimodmpsl
group
fisher
exact
test
howev
rat
die
within
day
administr
mgkg
rat
die
within
day
administr
mgkg
owe
high
mortal
observ
group
experi
perform
use
rat
figur
show
activ
liver
h
mpsl
treatment
imiquimodmpsl
mgkg
rat
administr
alter
rel
activ
day
howev
activ
repress
significantli
day
rat
administ
figur
imiquimodmpsl
vs
vs
fukushima
et
conduct
nationwid
epidemiolog
survey
japan
report
high
frequenc
sle
nephrot
syndrom
polymyositisdermatomyos
bronchial
asthma
thrombocytopen
purpura
underli
diseas
patient
corticosteroidinduc
onfh
recent
report
innat
immun
signal
via
contribut
pathogenesi
signal
contribut
pathogenesi
nephrot
signal
contribut
pathogenesi
polymyos
signal
contribut
pathogenesi
bronchial
signal
contribut
pathogenesi
thrombocytopen
report
show
innat
immun
signal
via
tlr
contribut
pathogenesi
underli
diseas
patient
corticosteroidinduc
onfh
previous
report
corticosteroid
treatment
lipopolysaccharid
lp
tlr
ligand
inject
induc
onfh
wistar
rat
suggest
signal
pathway
may
role
pathogenesi
onfh
present
studi
show
administr
ligand
combin
mpsl
treatment
result
develop
onfh
rat
contrast
report
megados
corticosteroid
therapi
recommend
nation
acut
spinal
cord
injuri
protocol
spinal
cord
injuri
result
trauma
induc
present
studi
onfh
observ
salinempsl
group
rat
receiv
tlr
ligand
indic
corticosteroid
alon
fail
induc
onfh
healthi
anim
sever
report
osteonecrosi
anim
model
use
corticosteroid
administr
alon
corticosteroid
administr
alon
led
develop
onfh
spontan
hypertens
rat
shr
howev
treatment
shr
model
differ
corticosteroid
administr
healthi
anim
genet
abnorm
background
report
corticosteroid
alon
led
develop
onfh
leghorn
histopatholog
examin
specimen
model
show
subchondr
bone
trabecula
femor
head
diminut
bone
trabecula
similar
appear
microct
imag
osteoporosi
anim
clear
whether
result
osteonecrosi
addit
yamamoto
et
report
osteonecrosi
rabbit
model
characterist
rabbit
model
osteonecrosi
develop
metaphysi
femor
head
treatment
healthi
rabbit
corticosteroid
hand
yamamoto
et
also
report
corticosteroid
treatment
lp
administr
led
develop
osteonecrosi
femor
head
metaphysi
rabbit
report
indic
administr
tlr
ligand
crucial
role
develop
femor
head
osteonecrosi
therefor
present
find
suggest
administr
tlr
ligand
combin
subsequ
corticosteroid
treatment
requir
trigger
onset
primari
corticosteroidinduc
onfh
rat
pathogenesi
underli
diseas
treat
corticosteroid
contribut
develop
corticosteroidinduc
onfh
highdos
corticosteroid
treatment
sever
acut
respiratori
syndrom
sar
infect
report
risk
factor
sar
viru
singlestrand
rna
viru
one
ligand
consequ
believ
pathogenesi
onfh
imiquimodmpsl
group
resembl
pathogenesi
onfh
corticosteroid
treatment
sar
infect
although
onfh
found
salinempsl
group
rat
fact
imiquimodsalin
rat
alcohol
corticosteroid
given
develop
onfh
lower
rate
indic
group
resembl
idiopath
onfh
result
suggest
signal
contribut
develop
idiopath
onfh
indic
infect
singlestrand
rna
viru
one
ligand
could
risk
factor
idiopath
onfh
infect
human
immunodefici
viru
singlestrand
rna
viru
alreadi
report
isol
risk
factor
idiopath
therefor
result
may
explain
pathogenesi
idiopath
onfh
patient
infect
singlestrand
rna
virus
among
underli
diseas
treat
corticosteroid
sle
report
frequent
observ
onfh
incid
onfh
sle
patient
corticosteroid
therapi
report
present
studi
imiquimodmpsl
cpgcmpsl
group
rat
develop
onfh
similar
incid
onfh
patient
sle
well
known
corticosteroid
mainli
metabol
liver
hepat
corticosteroidmetabol
recent
report
differ
liver
function
observ
patient
corticosteroidinduc
onfh
without
onfh
within
week
corticosteroid
moreov
ichiseki
et
report
disturb
oxid
stress
liver
observ
within
h
oxid
stressinduc
onfh
rat
model
report
suggest
variou
chang
liver
earli
phase
treatment
contribut
develop
onfh
present
studi
found
onfh
occur
within
day
mpsl
treatment
rat
suggest
detect
earli
phase
diseas
mpsl
treatment
import
clarifi
pathogenesi
onfh
also
found
activ
liver
day
significantli
repress
corticosteroid
treatment
ligand
administr
auphan
et
al
report
glucocorticoid
potent
antiinflammatori
immunosuppress
agent
repress
activ
via
glucocorticoid
receptor
one
critic
compon
inhibitori
effect
glucocorticoid
proinflammatori
immun
therefor
result
suggest
onfh
result
activ
via
pathway
follow
subsequ
repress
activ
corticosteroid
treatment
wherea
activ
affect
corticosteroid
treatment
therefor
result
indic
repress
activ
use
specif
inhibitor
interfer
develop
onfh
spite
simultan
repress
activ
result
mpsl
treatment
report
ikk
inhibitor
ikk
inhibitor
potenti
inhibit
present
studi
mpsl
treatment
significantli
repress
activ
imiquimodmpsl
compar
imiquimodsalin
rat
figur
accordingli
coadministr
mpsl
repress
activ
compar
imiquimodmpsl
rat
figur
contrast
mpsl
treatment
alter
activ
imiquimodmpsl
compar
imiquimodsalin
rat
figur
wherea
coadministr
mpsl
significantli
repress
activ
compar
imiquimodmpsl
rat
figur
coadministr
mpsl
significantli
lower
incid
onfh
repress
activ
find
confirm
effect
corticosteroid
treatment
transcript
factor
activ
liver
trigger
develop
onfh
repress
activ
corticosteroid
treatment
boost
develop
onfh
conclus
present
studi
show
corticosteroid
treatment
administr
ligand
caus
onfh
rat
differ
activ
liver
induc
corticosteroid
treatment
trigger
develop
onfh
although
remain
unclear
signal
transduct
liver
lead
femor
head
osteonecrosi
present
studi
suggest
pathogenesiscondit
underli
diseas
treat
corticosteroid
contribut
develop
onfh
might
help
explain
onfh
develop
develop
corticosteroid
therapi
dosag
expect
normal
inflammatori
statu
new
biolog
inflammatori
diseas
prevent
onfh
near
futur
